APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
49 hedge funds and large institutions have $14.7M invested in Aptose Biosciences, Inc. in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
22% less capital invested
Capital invested by funds: $18.8M → $14.7M (-$4.07M)
Holders
49
Holding in Top 10
–
Calls
$38K
Puts
$10K
Top Buyers
| 1 | +$190K | |
| 2 | +$61K | |
| 3 | +$35.7K | |
| 4 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$34.3K |
| 5 |
VF
Virtu Financial
New York
|
+$20K |
Top Sellers
| 1 | -$220K | |
| 2 | -$205K | |
| 3 | -$98.9K | |
| 4 |
VC
Voss Capital
Houston,
Texas
|
-$59.7K |
| 5 |
D.E. Shaw & Co
New York
|
-$58K |